Trifluridine/tipiracil (FTD/TPI) in patients (pts) aged >= 65 years with metastatic gastric/gastroesophageal junction cancer (mGC/mGEJC): Subgroup analysis from TAGS.

Shitara, KoheiDoi, ToshihikoHosaka, HisashiThuss-Patience, Peter C.Santoro, ArmandoJimenez-Fonseca, PaulaLongo, FedericoOzyilkan, OzgurCicin, IrfanPark, DavidTejani, Mohamedtaki AbdulazizZanan, AzizBilancia, DomenicoPericay, CarlesOzguroglu, MustafaAlsina, MariaMakris, LukasMcGuigan, SandraIlson, David H.2020-11-092020-11-0920190732-183Xhttp://hdl.handle.net/11727/5017enginfo:eu-repo/semantics/closedAccessTrifluridine/tipiracil (FTD/TPI) in patients (pts) aged >= 65 years with metastatic gastric/gastroesophageal junction cancer (mGC/mGEJC): Subgroup analysis from TAGS.Conference Object3715000487345805225